Biomarker: F008-IgE Maize/Corn

Overview

F008-IgE Maize/Corn measures immunoglobulin E (IgE) antibodies in serum that recognize maize, also called corn. IgE is involved in immediate-type allergic reactions, including symptoms affecting the skin, gastrointestinal tract, respiratory system, or multiple organ systems. A detectable or elevated result indicates sensitization to maize but does not by itself establish clinical allergy or predict reaction severity. The test is clinically useful when interpreted with a compatible history of reactions after maize exposure and, when necessary, a medically supervised oral food challenge.

Clinical Use Cases

Support evaluation of suspected IgE-mediated maize or corn allergy.
Identify sensitization to maize in patients with compatible food-related symptoms.
Contribute to the assessment of reactions such as urticaria, angioedema, gastrointestinal symptoms, wheezing, or anaphylaxis after maize exposure.
Help evaluate possible occupational allergy involving maize flour, dust, or pollen when interpreted with exposure history.
Support, but not replace, skin-prick testing and medically supervised oral food challenge.
Assist research on maize allergens and IgE-mediated allergic responses.

Specimen Types

Venous blood serum.
Plasma may be accepted by some laboratory methods, depending on the assay protocol.
Skin-prick testing with maize extract or fresh maize is an alternative in vivo assessment of sensitization, but it is not a specimen used for a serum-specific IgE measurement.

Measurement Methods

Automated allergen-specific immunoassays, commonly fluorescent enzyme immunoassays.
Enzyme-linked immunosorbent assays.
Chemiluminescent immunoassays.
Radioallergosorbent testing, an older method.
Component-resolved testing for selected maize allergen molecules may be available in specialized clinical or research settings.
Skin-prick testing is a complementary method, not a measurement of serum F008-IgE.

Test Preparation and Influencing Factors

Fasting is generally not required for a serum-specific IgE test.
Antihistamines generally do not interfere with serum-specific IgE testing, although they can affect skin-prick test results. Medication changes should be discussed with the ordering clinician.
Testing should be guided by a focused history of suspected maize exposure and symptoms. Broad food-allergen panels can produce clinically irrelevant positive results.
A positive result indicates IgE sensitization and may occur without symptoms after eating maize.
The concentration of maize-specific IgE does not reliably predict reaction severity.
Cross-sensitization to related foods or pollens may contribute to a positive result and requires clinical interpretation.
Results can vary according to the maize extract, assay platform, reporting units, and laboratory cutoff.
Total IgE, eczema, smoking, parasitic infection, and other allergic conditions may influence overall IgE concentrations but do not establish maize allergy.
A medically supervised oral food challenge remains the reference method when the diagnosis is uncertain.